American College of Allergy, Asthma & Immunology

Shorts

Phase 3 NATRON Trial Shows Benefits of Benralizumab for HES
1:15
Phase 3 NATRON Trial Shows Benefits of Benralizumab for HES
a year ago
by
Princess Ogbogu, MD
Dupilumab Cuts Surgery Need in Patients with Allergic Fungal Rhinosinusitis
0:59
Dupilumab Cuts Surgery Need in Patients with Allergic Fungal Rhinosinusitis
a year ago
by
Amber Luong, MD, PhD

Latest Content

The growing market for home air fresheners is impacting respiratory health, according to Stanley Fineman, MD, MBA, president-elect of ACAAI, associate clinical professor department of pediatrics, Emory University School of Medicine, Atlanta Allergy & Allergy Clinic.